respiratory

Chiesi starts rare diseases division, ahead of potential Fabry disease filing

https://pharmaphorum.com/news/chiesi-starts-rare-diseases-division-as-fabry-treatment/

FDA clears emergency diagnostic as coronavirus fears mount

https://pharmaphorum.com/news/fda-clears-emergency-diagnostic-as-coronavirus-fears-mount/

FDA sets June date for latest review of Merck’s last-ditch antibiotic

https://pharmaphorum.com/news/fda-sets-june-date-for-latest-review-of-mercks-last-ditch-antibiotic/

Chasing Mylan, Hikma tries again with rejected generic Advair in US

https://pharmaphorum.com/news/chasing-mylan-hikma-tries-again-with-rejected-generic-advair-in-us/

FDA rejection scuppers AZ’s hopes of a COPD triple clash with GSK

https://pharmaphorum.com/news/fda-rejection-scuppers-azs-hopes-of-a-copd-triple-clash-with-gsk/

Novartis announces positive results from asthma combinations

https://pharmaphorum.com/news/novartis-announces-positive-results-from-asthma-combination-therapies/

Device advancements to be discussed at the Respiratory Drug Delivery Conference 2019

https://pharmaphorum.com/partner-content/device-advancements-to-be-discussed-at-the-respiratory-drug-delivery-conference-2019/

Key Opinion Leaders to present at the Respiratory Drug Delivery Conference

https://pharmaphorum.com/partner-content/key-opinion-leaders-to-present-at-the-respiratory-drug-delivery-conference/

EU clears GSK’s asthma drug Nucala in patient-friendly format

https://pharmaphorum.com/news/eu-clears-gsks-asthma-drug-nucala-in-patient-friendly-format/

1 2 3 4 5 >»

Close in 10 seconds

Pharmaphorum.com

Search